AU2003239203A1 - Furano- and thienopyrimidines as neurokinase inhibitors - Google Patents

Furano- and thienopyrimidines as neurokinase inhibitors

Info

Publication number
AU2003239203A1
AU2003239203A1 AU2003239203A AU2003239203A AU2003239203A1 AU 2003239203 A1 AU2003239203 A1 AU 2003239203A1 AU 2003239203 A AU2003239203 A AU 2003239203A AU 2003239203 A AU2003239203 A AU 2003239203A AU 2003239203 A1 AU2003239203 A1 AU 2003239203A1
Authority
AU
Australia
Prior art keywords
neurokinase
thienopyrimidines
furano
inhibitors
neurokinase inhibitors
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003239203A
Inventor
Kim Andersen
Thomas Balle
Jakob Felding
Samms Anette Graven
Kristensen Jesper Langgard
Ejner Knud Moltzen
Jan Torleif Pedersen
Mario Rottlander
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
H Lundbeck AS
Original Assignee
H Lundbeck AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by H Lundbeck AS filed Critical H Lundbeck AS
Publication of AU2003239203A1 publication Critical patent/AU2003239203A1/en
Abandoned legal-status Critical Current

Links

AU2003239203A 2002-01-29 2003-01-28 Furano- and thienopyrimidines as neurokinase inhibitors Abandoned AU2003239203A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA200200140 2002-01-29
US60/352,650 2002-01-29

Publications (1)

Publication Number Publication Date
AU2003239203A1 true AU2003239203A1 (en) 2003-09-02

Family

ID=

Similar Documents

Publication Publication Date Title
AU2003202263A1 (en) Roh-kinase inhibitors
AU2003255376A1 (en) Piperidine-derivatives as pde4 inhibitors
AU2003271566A1 (en) Pyrrolopyrazines as kinase inhibitors
AU2003278088A1 (en) Heteroaryloxy-substituted phenylaminopyrimidines as rho-kinase inhibitors
AU2003249442A1 (en) Kinase inhibitors
AU2003222055A1 (en) Kinase inhibitors
AU2003259749A1 (en) 3-pyrrolyl-pyridopyrazoles and 3-pyrrolyl-indazoles as novel kinase inhibitors
PL373146A1 (en) Pyridazinone-derivatives as pde4 inhibitors
AU2003224111A1 (en) Substituted pyrazolo-pyrimidine-4-ones
AU2003258045A1 (en) Novel gamma-lactams as beta-secretase inhibitors
AU2003253880A1 (en) Novel kinases
AU2003284399A1 (en) Plk inhibitors
AU2003238043A1 (en) Substituted imidazotriazines
AU2003245984A1 (en) Hetero-cyclicaly substituted imidazotriazines
AU2003249683A1 (en) Nf-:b inhibitors
AU2003289386A1 (en) Jnk inhibitors
AU2003255952A1 (en) Oxytocin inhibitors
AU2003277674A1 (en) Novel parp inhibitors
AU2003269140A1 (en) Clopidogrel
AU2003230392A1 (en) Beta-secretase inhibitors
IL164898A0 (en) Heterotricyclyl 6-alkylidene-penems as beta-lactamase inhibitors
AU2003215635A1 (en) Thiazol-2-yl-imine compounds as pde-7 inhibitors
AU2003295427A1 (en) Flaviviris fusion inhibitors
AU2003299901A1 (en) Thrombin inhibitors
AU2003212366A1 (en) Substituted 4-aminocyclohexanols